Ultralife Corporation
ULBI
$6.71
-$0.01-0.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.74% | 3.66% | 9.95% | 17.37% | 26.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.74% | 3.66% | 9.95% | 17.37% | 26.44% |
| Cost of Revenue | 3.35% | 2.26% | 6.74% | 12.25% | 21.17% |
| Gross Profit | 0.96% | 7.94% | 20.17% | 34.70% | 44.70% |
| SG&A Expenses | 12.37% | 8.50% | 2.31% | 3.77% | 1.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.57% | 3.57% | 5.97% | 10.35% | 16.71% |
| Operating Income | -29.80% | 5.17% | 105.03% | 314.33% | 2,902.67% |
| Income Before Tax | -45.88% | -8.95% | 94.15% | 247.59% | 2,727.89% |
| Income Tax Expenses | -36.99% | -3.02% | 23.48% | 127.18% | 1,439.90% |
| Earnings from Continuing Operations | -48.26% | -10.56% | 120.63% | 294.74% | 3,639.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -437.93% | -412.90% | -488.89% | 186.67% | 1,066.67% |
| Net Income | -49.34% | -12.30% | 119.29% | 297.59% | 3,613.13% |
| EBIT | -29.80% | 5.17% | 105.03% | 314.33% | 2,902.67% |
| EBITDA | -19.46% | 5.50% | 62.88% | 137.50% | 267.82% |
| EPS Basic | -50.30% | -13.65% | 115.70% | 291.07% | 3,583.15% |
| Normalized Basic EPS | -39.96% | 4.97% | 66.64% | 201.54% | 2,381.73% |
| EPS Diluted | -50.06% | -12.01% | 119.63% | 300.60% | 2,509.92% |
| Normalized Diluted EPS | -40.36% | 4.02% | 65.03% | 198.60% | 2,372.59% |
| Average Basic Shares Outstanding | 2.06% | 2.11% | 1.98% | 1.54% | 0.90% |
| Average Diluted Shares Outstanding | 2.59% | 2.95% | 3.06% | 2.44% | 1.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |